Core Laboratories Nv Stock Performance

CLB Stock  USD 18.32  0.19  1.05%   
On a scale of 0 to 100, Core Laboratories holds a performance score of 12. The firm shows a Beta (market volatility) of 2.43, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Laboratories will likely underperform. Please check Core Laboratories' value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Core Laboratories' price patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Core Laboratories NV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting essential indicators, Core Laboratories sustained solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
6.96
Five Day Return
11.64
Year To Date Return
6.96
Ten Year Return
(82.17)
All Time Return
504.33
Forward Dividend Yield
0.0024
Payout Ratio
0.0519
Last Split Factor
2:1
Forward Dividend Rate
0.04
Dividend Date
2025-11-24
1
Core Laboratories Falls Amid Escalating Trade Tensions
10/13/2025
2
Core Laboratories Q3 Earnings Surpass Estimates, Decline YY
10/24/2025
3
Core Laboratories Skyrockets After Beating Estimates in Q3 - Insider Monkey
10/27/2025
4
Earnings call transcript Core Laboratories Q3 2025 results miss expectations - Investing.com
10/30/2025
5
Core Laboratories Inc Q3 2025 Earnings Call Highlights Strong Revenue Growth and ...
11/05/2025
6
Core Laboratories Inc.s Stock Is Going Strong Is the Market Following Fundamentals
11/13/2025
7
What dividend safety rating applies to Core Laboratories Inc. stock - Trade Volume Report Real-Time Volume Surge Alerts - newser.com
11/18/2025
8
A Look At The Fair Value Of Core Laboratories Inc.
11/21/2025
 
Core Laboratories dividend paid on 24th of November 2025
11/24/2025
9
Disposition of 864 shares by Sow Teo of Core Laboratories subject to Rule 16b-3
12/01/2025
10
Disposition of 180722 shares by Lawrence Bruno of Core Laboratories subject to Rule 16b-3
12/31/2025
11
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
01/05/2026
Begin Period Cash Flow15.1 M
Total Cashflows From Investing Activities-6.4 M

Core Laboratories Relative Risk vs. Return Landscape

If you would invest  1,207  in Core Laboratories NV on October 8, 2025 and sell it today you would earn a total of  606.00  from holding Core Laboratories NV or generate 50.21% return on investment over 90 days. Core Laboratories NV is generating 0.7734% of daily returns assuming volatility of 4.8183% on return distribution over 90 days investment horizon. In other words, 43% of stocks are less volatile than Core, and above 85% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Core Laboratories is expected to generate 6.43 times more return on investment than the market. However, the company is 6.43 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Core Laboratories Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Core Laboratories NV, and traders can use it to determine the average amount a Core Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1605

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsCLB
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns
Based on monthly moving average Core Laboratories is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Core Laboratories by adding it to a well-diversified portfolio.

Core Laboratories Fundamentals Growth

Core Stock prices reflect investors' perceptions of the future prospects and financial health of Core Laboratories, and Core Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Core Stock performance.

About Core Laboratories Performance

By analyzing Core Laboratories' fundamental ratios, stakeholders can gain valuable insights into Core Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Core Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Core Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 44.81  27.79 
Return On Tangible Assets 0.06  0.06 
Return On Capital Employed 0.11  0.20 
Return On Assets 0.05  0.05 
Return On Equity 0.12  0.14 

Things to note about Core Laboratories performance evaluation

Checking the ongoing alerts about Core Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Core Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Core Laboratories appears to be risky and price may revert if volatility continues
Over 99.0% of the company shares are held by institutions such as insurance companies
On 24th of November 2025 Core Laboratories paid $ 0.01 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
Evaluating Core Laboratories' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Core Laboratories' stock performance include:
  • Analyzing Core Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Core Laboratories' stock is overvalued or undervalued compared to its peers.
  • Examining Core Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Core Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Core Laboratories' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Core Laboratories' stock. These opinions can provide insight into Core Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Core Laboratories' stock performance is not an exact science, and many factors can impact Core Laboratories' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes